The unique association between the level of plateletcrit and the prevalence of diabetic kidney disease: a cross-sectional study
Frontiers in Endocrinology · 2024
DOI: 10.3389/fendo.2024.1345293 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Endocrinology, 2024. Verfasst von Shuwu Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus, Type 2, Blood Platelets. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Objective
The activation of platelets in individuals with type 2 diabetes mellitus (T2DM) triggers inflammation and hemodynamic abnormalities, contributing to the development of diabetic kidney disease (DKD). Despite this, research into the relationship between plateletcrit (PCT) levels and DKD is sparse, with inconsistent conclusions drawn regarding the connection between various platelet parameters and DKD. This highlights the necessity for comprehensive, large-scale population studies. Therefore, our objective is to explore the association between PCT levels and various platelet parameters in relation to DKD.
Methods
In this cross-sectional study, hematological parameter data were collected from a cohort of 4,302 hospitalized Chinese patients. We analyzed the relationships between PCT, platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), platelet large cell ratio (P-LCR), and DKD, along with the urinary albumin-to-creatinine ratio (UACR), and estimated glomerular filtration rate (eGFR). Receiver operating characteristic (ROC) curve analysis was conducted to evaluate the diagnostic potential of these parameters.
Results
DKD patients exhibited significantly higher PCT levels compared to those without DKD. Multivariate regression analysis identified elevated PCT and PLT levels as potential independent risk factors for both DKD and UACR, while lower MPV levels might serve as independent protective factors for eGFR. The areas under the ROC curve for PCT in relation to DKD and UACR (≥30 mg/g) were 0.523 and 0.526, respectively. The area under the ROC curve for PLT in relation to UACR (≥30 mg/g) was 0.523.
Conclusion
PCT demonstrates a weak diagnostic value for T2DM patients at risk of developing DKD and experiencing proteinuria, and PLT shows a similarly modest diagnostic utility for detecting proteinuria. These insights contribute to a deeper understanding of the complex dynamics involved in DKD. Additionally, incorporating these markers into routine clinical assessments could enhance risk stratification, facilitating early interventions and personalized management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Beijing University of Chinese Medicine, Beijing, China.
Förderung
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Wei, S., Pan, X., Xiao, Y., Chen, R., & Wei, J. (2024). The unique association between the level of plateletcrit and the prevalence of diabetic kidney disease: a cross-sectional study. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1345293
Vancouver
Wei S, Pan X, Xiao Y, Chen R, Wei J. The unique association between the level of plateletcrit and the prevalence of diabetic kidney disease: a cross-sectional study. Frontiers in Endocrinology. 2024. doi:10.3389/fendo.2024.1345293
BibTeX
@article{Wei2024,
author = {Wei, Shuwu and Pan, Xinyu and Xiao, Yao and Chen, Ruishuang and Wei, Junping},
title = {The unique association between the level of plateletcrit and the prevalence of diabetic kidney disease: a cross-sectional study},
journal = {Frontiers in Endocrinology},
year = {2024},
doi = {10.3389/fendo.2024.1345293}
}
EUVIMED